Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

INTRODUCTIONThe epidermal growth factor receptor inhibitors (EGFRIs), cetuximab and panitumumab, represent an effective treatment option for patients affected by metastatic colorectal cancer (mCRC); furthermore, they are relatively devoid of systemic toxicities, which are commonly observed with stan...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of pharmacology & pharmacotherapeutics 2013, Vol.4, p.S78-S85
Hauptverfasser:	Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista
Format:	Report
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!